Calendar Iovance Biotherapeutics, Inc.

Equities

IOVA

US4622601007

Market Closed - Nasdaq 04:30:00 2024-03-18 pm EDT 5-day change 1st Jan Change
14.03 USD +0.86% Intraday chart for Iovance Biotherapeutics, Inc. -7.09% +72.57%

Chart calendar Iovance Biotherapeutics, Inc.

0df4b0151eb9bc62267e4c35e9fe343a.f2fWRvSjIMPEucqravv96i2aRvBOF_iOk8MT9jocad8.Ez-aLabSE_SX7aOaXLWUqxzrDr0eco-j461mxG0qHZQcEJQ_rMVtoYLt-g~1b87eb047d2ab07bae1a1089129a67c5

Upcoming events on Iovance Biotherapeutics, Inc.

2024-03-26 01:30 pm H.C. Wainwright Cell Therapy Virtual Conference
2024-05-06 Q1 2024 Earnings Release (Projected)
2024-07-31 Q2 2024 Earnings Release (Projected)
2024-11-05 Q3 2024 Earnings Release (Projected)
2025-02-25 Q4 2024 Earnings Release (Projected)

Past events on Iovance Biotherapeutics, Inc.

2024-03-12 10:45 am Barclays Global Healthcare Conference
2024-03-04 11:10 am TD Cowen Health Care Conference
2024-02-28 04:30 pm Q4 2023 Earnings Call
2024-02-28 04:01 pm Q4 2023 Earnings Release
2024-02-16 04:15 pm AMTAGVI™ FDA Approval Call
2023-11-07 04:30 pm Q3 2023 Earnings Call
2023-11-07 04:01 pm Q3 2023 Earnings Release
2023-11-04 12:00 pm Society for Immunotherapy of Cancer Meeting - Long-term Efficacy and Safety of Lifileucel Tumor
2023-11-04 12:00 pm Society for Immunotherapy of Cancer Meeting - Study of Lifileucel Tumor Infiltrating Lymphocyte
2023-11-03 12:00 pm Society for Immunotherapy of Cancer Meeting
2023-10-21 09:15 am European Society for Medical Oncology Congress
2023-09-11 11:15 pm International Association for the Study of Lung Cancer World Conference - Adam J. Schoenfeld
2023-09-11 06:00 am International Association for the Study of Lung Cancer World Conference - Dean Fennell
2023-09-07 12:45 pm Wells Fargo Healthcare Conference
2023-08-08 04:30 pm Q2 2023 Earnings Call
2023-08-08 04:01 pm Q2 2023 Earnings Release
2023-06-26 05:00 pm Investor Meeting - Key Opinion Leaders
2023-06-09 11:00 am Jefferies Global Healthcare Conference
2023-06-06 11:00 am Annual General Meeting
2023-06-03 02:15 pm American Society of Clinical Oncology Conference - Abstract No:TPS9607

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
1,19
2,12
-44.03%

161

EBITDA
Million USD
Released
Forecast
Spread
0,00
0,00
-
-261
-256
-1.87%
-340
-330
-2.8%
-390
-389
-0.09%
-449
-420
-6.87%

-302

EBIT
Million USD
Released
Forecast
Spread
-207
-196
-5.73%
-262
-260
-0.63%
-343
-331
-3.63%
-399
-395
-0.91%
-461
-451
-2.01%

-359

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-198
-187
-5.92%
-260
-257
-0.88%
-342
-330
-3.78%
-396
-394
-0.52%
-448
-440
-1.63%

-352

Net income
Million USD
Released
Forecast
Spread
-198
-187
-5.92%
-260
-257
-0.92%
-342
-330
-3.78%
-396
-394
-0.52%
-444
-439
-1.17%

-352

EPS
USD
Released
Forecast
Spread
-1,59
-1,50
-6.14%
-1,88
-1,85
-1.9%
-2,23
-2,15
-3.63%
-2,49
-2,49
-0.15%
-1,89
-1,88
-0.8%

-1,30

Announcement Date25/02/2025/02/2124/02/2228/02/2328/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,24
5,38
-95.57%
0,47
4,89
-90.4%
0,48
1,40
-65.55%

2,09


30,5


60,6


77,3


119

EBITDA
Million USD
Released
Forecast
Spread
-98,1
-88,2
-11.25%
-89,9
-100
10.26%
-97,5
-101
3.19%
-97,9
-106
7.78%
-104
-105
1.12%
-108
-110
1.56%
-107









-128


-129


-128


-132




EBIT
Million USD
Released
Forecast
Spread
-99,5
-87,4
-13.83%
-91,7
-100
8.67%
-99,7
-96,0
-3.87%
-100
-102
1.28%
-107
-103
-3.46%
-111
-111
0.11%
-110
-172
36.16%
-118
-109
-8.53%
-121
-112
-8.09%

-111


-97,7


-76,0


-67,0


-43,8

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-99,3
-86,8
-14.45%
-91,6
-100
8.5%
-99,3
-95,9
-3.55%
-99,6
-100
0.76%
-105
-103
-2.07%
-107
-131
17.98%
-107
-171
37.27%
-115
-107
-7.19%
-118
-111
-6.41%

-113


-98,2


-78,4


-73,1


-40,8

Net income
Million USD
Released
Forecast
Spread
-99,3
-86,8
-14.45%
-91,6
-100
8.5%
-99,3
-95,9
-3.55%
-99,6
-100
0.49%
-105
-103
-2.07%
-107
-131
17.98%
-107
-171
37.55%
-114
-107
-6.04%
-116
-111
-4.97%

-113


-98,2


-78,5


-73,1


-40,8

EPS
USD
Released
Forecast
Spread
-0,63
-0,56
-13.05%
-0,58
-0,64
9.38%
-0,63
-0,61
-4.05%
-0,63
-0,64
1.14%
-0,64
-0,64
-0.43%
-0,50
-0,75
33.42%
-0,47
-0,85
44.79%
-0,46
-0,45
-1.77%
-0,45
-0,44
-2.51%

-0,43


-0,36


-0,29


-0,27


-0,06

Announcement Date24/02/2205/05/2204/08/2203/11/2228/02/2309/05/2308/08/2307/11/2328/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise